Cumberland Pharmaceuticals (CPIX) Net Margin (2010 - 2026)
Cumberland Pharmaceuticals' (CPIX) quarterly Net Margin came in at 2567.87% in Q2 2026, down 237480.0% year-over-year from N/an in Q2 2025, and down 7365.23% quarter-over-quarter from 34.4% in Q1 2026.
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) Net Margin (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has disclosed Net Margin across 17 years of filings, most recently posting 2567.87% for Q2 2026.
- In Q2 2026, Net Margin fell 237480.0% year-over-year to 2567.87%; the TTM figure through Jun 2026 stood at 34.47% (down 2522.0% YoY), while the FY2025 annual figure was 6.4%, up 1061.0% from the prior year.
- Net Margin came in at 2567.87% for Q2 2026 at Cumberland Pharmaceuticals, down from 34.4% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 10.66% in Q1 2025 to a low of 2567.87% in Q2 2026.
- Average Net Margin over 5 years is 167.33%, with a median of 15.08% recorded in 2022.
- Year-over-year, Net Margin surged 4916 bps in 2024 and tumbled 237480 bps in 2026.
- Over 5 years, Net Margin stood at 26.96% in 2022, then plunged by 150 bps to 67.38% in 2023, then soared by 73 bps to 18.22% in 2024, then surged by 43 bps to 10.35% in 2025, then slumped by 24716 bps to 2567.87% in 2026.
- Per Business Quant data, the three most recent Net Margin figures were 2567.87% in Q2 2026, 34.4% in Q1 2026, and 10.35% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.38 Bn | 624.62 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 443.13 Bn | 436.56 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 365.40 Bn | 358.26 Bn | 12.21 Bn | -8.05% |
| 4 | Novartis Ag | 266.79 Bn | 259.10 Bn | 11.24 Bn | 22.65% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -1.58% |
| 6 | Sanofi | 52.39 Bn | 45.00 Bn | 10.79 Bn | 2.96% |
| 7 | Revolution Medicines | 43.92 Bn | 43.92 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 34.98% |
| 9 | United Therapeutics | 21.55 Bn | 18.88 Bn | 683.80 Mn | 42.51% |
| 10 | Cumberland Pharmaceuticals | 95.51 Mn | 91.65 Mn | - | -2,567.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,567.87% |
| Mar 31, 2026 | -34.40% |
| Dec 31, 2025 | -10.35% |
| Sep 30, 2025 | -23.50% |
| Jun 30, 2025 | -193.07% |
| Mar 31, 2025 | 10.66% |
| Dec 31, 2024 | -18.22% |
| Sep 30, 2024 | -16.92% |
| Jun 30, 2024 | -11.20% |
| Mar 31, 2024 | -22.39% |
| Dec 31, 2023 | -67.38% |
| Sep 30, 2023 | -10.54% |
| Jun 30, 2023 | 7.92% |
| Mar 31, 2023 | 1.87% |
| Dec 31, 2022 | -26.96% |
| Sep 30, 2022 | -3.71% |
| Jun 30, 2022 | -13.25% |
| Mar 31, 2022 | -12.55% |
| Dec 31, 2021 | -46.69% |
| Sep 30, 2021 | -13.46% |